Net Income/(Loss) per Share

3 Months Ended

Mar. 31, 2023

Net Income (Loss) per Share

The following table presents the reconciliation of net income (loss) to net loss used in computing basic and diluted net income (loss) per share of Common Stock attributable to common stockholders:


	March 31, 2023		March 31, 2022
Net income (loss) used in computing basic net income (loss) per share of Common Stock attributable to common stockholders	$	6,487	$	(153,098)
Less: Dilutive impact of SPA Warrants	(11,897)		—
Less: Dilutive impact of conversion of SPA notes and settlement of make-whole provisions	(59,331)		—
Net loss used in computing diluted net loss per share of Common Stock attributable to common stockholders	$	(64,741)	$	(153,098)

The following table presents the reconciliation of basic to diluted weighted average shares used in computing net income/(loss) per share of Common Stock attributable to common stockholders. In computing the weighted average shares using the “if-converted” method in accordance with ASC 260-10, Earning per Share the Company uses the average Interest Conversion Price during the three months ended March 31, 2023.


	March 31, 2023	March 31, 2022
Weighted average shares used in computing net income per share of common stock, basic	657,565,442	322,211,392
Add: Shares issuable upon exercise of SPA Warrants	19,121,103	—
Add: Shares issuable upon conversion of SPA notes and settlement of make-whole provisions	311,952,117	—
Weighted average shares used in computing net loss per share of common stock, diluted	988,638,662	322,211,392

The following table presents the potentially dilutive shares that were excluded from the computation of diluted net income (loss) per share of Common Stock attributable to common stockholders, because their effect was anti-dilutive:


	March 31, 2023	March 31, 2022
Shares issuable upon exercise of SPA Warrants, excluding amounts included above in Diluted EPS	45,571,419	—
Shares issuable upon conversion of notes and settlement of Make-Whole provisions, excluding amounts included above in Diluted EPS	—	9,009,210
Other warrants	29,454,593	4,544,258
Stock-based compensation awards – Options	37,181,872	43,781,815
Stock-based compensation awards – RSUs	20,131,111	—
Public warrants	23,540,988	22,977,568
Private warrants	111,131	674,551
Total	155,991,114	80,987,402